This November, health economics and outcomes research (HEOR) professionals from across Europe will gather at ISPOR Europe 2022 to share their latest findings, collaborate with colleagues, attend workshops led by HEOR experts and more. ISPOR is seeking research and case study abstract submissions for […]
ISPOR Publishes HTA Deliberative Process Guidance
ISPOR – The Professional Society for Health Economics and Outcomes Research has published a new guidance on deliberative processes for health technology assessment (HTA). The guidance, published in Value in Health, provides a detailed checklist for setting up an efficient and transparent […]
Outgoing ISPOR President Isao Kamae Reflects on the Past Year
At the beginning of his final month as ISPOR President, Isao Kamae, DrPH, MD, looks back on the past year at ISPOR. Although his term has been largely virtual, he’s been pleased to lead the first in-person conference since the pandemic started. In his farewell address, he describes the five words he […]
2021 ISPOR Annual Report
ISPOR has just released its annual report covering the work of ISPOR and the health economics and outcomes research (HEOR) community during 2021. The report includes the newly published ISPOR Science Strategy and updates on the organization’s efforts to further its Strategic Plan Update 2024. In […]
Call for Abstracts and Reviewers: ISPOR Europe 2022
ISPOR is seeking abstracts for its upcoming ISPOR Europe 2022 conference. ISPOR Europe 2022 is the leading health economics and outcomes research (HEOR) conference in Europe, attracting professionals from academia, industry, and regulatory bodies. Poster and podium presentations are accepted. […]
ISPOR 2022 Plenary Session: HTA on the Run
On May 16th, ISPOR 2022 will open with its welcome plenary session entitled, “HTA on the Run.” In the session, speakers will explain how and why health technology assessment (HTA) agencies have adopted accelerated processes. In addition, 3 case studies will be presented that demonstrate different […]
ISPOR Releases Quarterly News Around the Globe Publication
ISPOR has just released the latest News Across the Globe. This issue of the quarterly publication covers challenges of cost analysis in Mexico, health policy reform in Egypt, health economics and outcomes research (HEOR) perspectives on health insurance reform in China, and more. News Across the […]
2022-2023 ISPOR Board of Directors Election – Last Chance to Vote
April 1st is the last day to submit nominations for the 2022-2023 ISPOR Board of Directors election. On the 2022 ballot are two candidates for President-Elect, Raoh-Fang (Jasmin) Pwu, PhD, the director of the Taiwan National Hepatitis C Program Office, and Brian O’Rourke, PharmD, President of Brian […]
New Value in Health Article: Limitations of Conventional Cost-Effectiveness Analysis and the ISPOR Value Flower
Conventional methods of cost-effectiveness often overlook key value elements for patients. The “ISPOR Value Flower,” introduced in the 2018 ISPOR Special Task Force (STF) on US Value Assessments, is a model for augmented value-assessment that accounts for several of these novel, underappreciated […]
About Real-World Evidence: New ISPOR Microsite
ISPOR has announced the launch of its new microsite, “About Real-World Evidence.” This resource, produced in partnership with the Bristol Myers Squibb-Pfizer Alliance, provides content to introduce healthcare professionals to the real-world evidence (RWE) and health economics and outcomes research […]
